nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Epirubicin—ovarian cancer	0.119	0.519	CrCtD
Daunorubicin—Doxorubicin—ovarian cancer	0.11	0.481	CrCtD
Daunorubicin—NR5A1—ovarian cancer	0.0981	0.752	CbGaD
Daunorubicin—Topoisomerase Inhibitors—Topotecan—ovarian cancer	0.0837	0.28	CiPCiCtD
Daunorubicin—Anthracyclines—Epirubicin—ovarian cancer	0.0735	0.246	CiPCiCtD
Daunorubicin—Anthracyclines—Doxorubicin—ovarian cancer	0.068	0.227	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Epirubicin—ovarian cancer	0.0384	0.128	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Doxorubicin—ovarian cancer	0.0355	0.119	CiPCiCtD
Daunorubicin—YWHAG—Epirubicin—ovarian cancer	0.0261	0.193	CbGbCtD
Daunorubicin—Doxorubicin—Epirubicin—ovarian cancer	0.0254	0.173	CrCrCtD
Daunorubicin—Idarubicin—Epirubicin—ovarian cancer	0.0254	0.173	CrCrCtD
Daunorubicin—Valrubicin—Epirubicin—ovarian cancer	0.0254	0.173	CrCrCtD
Daunorubicin—CYP1B1—ovarian cancer	0.0252	0.193	CbGaD
Daunorubicin—Idarubicin—Doxorubicin—ovarian cancer	0.0235	0.16	CrCrCtD
Daunorubicin—Epirubicin—Doxorubicin—ovarian cancer	0.0235	0.16	CrCrCtD
Daunorubicin—Valrubicin—Doxorubicin—ovarian cancer	0.0235	0.16	CrCrCtD
Daunorubicin—YWHAG—Doxorubicin—ovarian cancer	0.0139	0.102	CbGbCtD
Daunorubicin—ABCC10—Paclitaxel—ovarian cancer	0.0075	0.0554	CbGbCtD
Daunorubicin—ABCB1—ovarian cancer	0.00722	0.0553	CbGaD
Daunorubicin—XDH—Carboplatin—ovarian cancer	0.00577	0.0427	CbGbCtD
Daunorubicin—POR—Doxorubicin—ovarian cancer	0.00576	0.0425	CbGbCtD
Daunorubicin—ABCC10—Docetaxel—ovarian cancer	0.00542	0.0401	CbGbCtD
Daunorubicin—TOP2A—Epirubicin—ovarian cancer	0.0053	0.0391	CbGbCtD
Daunorubicin—ABCC6—Doxorubicin—ovarian cancer	0.00529	0.0391	CbGbCtD
Daunorubicin—ABCB11—Paclitaxel—ovarian cancer	0.00408	0.0301	CbGbCtD
Daunorubicin—CYP1B1—Paclitaxel—ovarian cancer	0.00408	0.0301	CbGbCtD
Daunorubicin—ABCC10—Doxorubicin—ovarian cancer	0.00404	0.0299	CbGbCtD
Daunorubicin—ABCG2—Topotecan—ovarian cancer	0.00392	0.0289	CbGbCtD
Daunorubicin—XDH—Doxorubicin—ovarian cancer	0.00331	0.0244	CbGbCtD
Daunorubicin—NR5A1—corpus luteum—ovarian cancer	0.00313	0.194	CbGeAlD
Daunorubicin—CYP1B1—Docetaxel—ovarian cancer	0.00295	0.0218	CbGbCtD
Daunorubicin—ABCC1—Epirubicin—ovarian cancer	0.00294	0.0217	CbGbCtD
Daunorubicin—ABCC1—Paclitaxel—ovarian cancer	0.0029	0.0214	CbGbCtD
Daunorubicin—TOP2A—Doxorubicin—ovarian cancer	0.00282	0.0208	CbGbCtD
Daunorubicin—NR5A1—ovarian follicle—ovarian cancer	0.00245	0.152	CbGeAlD
Daunorubicin—ABCB11—Doxorubicin—ovarian cancer	0.0022	0.0162	CbGbCtD
Daunorubicin—CYP1B1—Doxorubicin—ovarian cancer	0.0022	0.0162	CbGbCtD
Daunorubicin—ABCC2—Paclitaxel—ovarian cancer	0.00214	0.0158	CbGbCtD
Daunorubicin—ABCC1—Docetaxel—ovarian cancer	0.00209	0.0155	CbGbCtD
Daunorubicin—ABCC2—Carboplatin—ovarian cancer	0.00202	0.0149	CbGbCtD
Daunorubicin—ABCG2—Paclitaxel—ovarian cancer	0.00194	0.0143	CbGbCtD
Daunorubicin—ABCG2—Carboplatin—ovarian cancer	0.00182	0.0135	CbGbCtD
Daunorubicin—ABCC1—Doxorubicin—ovarian cancer	0.00156	0.0115	CbGbCtD
Daunorubicin—ABCC2—Docetaxel—ovarian cancer	0.00155	0.0115	CbGbCtD
Daunorubicin—ABCB1—Topotecan—ovarian cancer	0.00141	0.0104	CbGbCtD
Daunorubicin—ABCG2—Docetaxel—ovarian cancer	0.0014	0.0104	CbGbCtD
Daunorubicin—ABCC2—Doxorubicin—ovarian cancer	0.00116	0.00854	CbGbCtD
Daunorubicin—CYP3A5—Paclitaxel—ovarian cancer	0.00107	0.00793	CbGbCtD
Daunorubicin—ABCG2—Doxorubicin—ovarian cancer	0.00104	0.00772	CbGbCtD
Daunorubicin—ABCB1—Vinorelbine—ovarian cancer	0.000995	0.00735	CbGbCtD
Daunorubicin—CYP3A4—Topotecan—ovarian cancer	0.000846	0.00625	CbGbCtD
Daunorubicin—CYP3A5—Docetaxel—ovarian cancer	0.000776	0.00574	CbGbCtD
Daunorubicin—ABCB1—Paclitaxel—ovarian cancer	0.000699	0.00516	CbGbCtD
Daunorubicin—CYP3A4—Vinorelbine—ovarian cancer	0.000596	0.0044	CbGbCtD
Daunorubicin—ABCB1—Docetaxel—ovarian cancer	0.000505	0.00373	CbGbCtD
Daunorubicin—CYP3A4—Paclitaxel—ovarian cancer	0.000419	0.00309	CbGbCtD
Daunorubicin—ABCB1—Doxorubicin—ovarian cancer	0.000377	0.00278	CbGbCtD
Daunorubicin—CYP3A4—Docetaxel—ovarian cancer	0.000303	0.00224	CbGbCtD
Daunorubicin—YWHAG—myometrium—ovarian cancer	0.000228	0.0141	CbGeAlD
Daunorubicin—CYP3A4—Doxorubicin—ovarian cancer	0.000226	0.00167	CbGbCtD
Daunorubicin—NR5A1—gonad—ovarian cancer	0.000225	0.0139	CbGeAlD
Daunorubicin—TOP2B—myometrium—ovarian cancer	0.000219	0.0136	CbGeAlD
Daunorubicin—TOP2B—embryo—ovarian cancer	0.000211	0.0131	CbGeAlD
Daunorubicin—NR5A1—female reproductive system—ovarian cancer	0.000201	0.0124	CbGeAlD
Daunorubicin—NR5A1—female gonad—ovarian cancer	0.000183	0.0113	CbGeAlD
Daunorubicin—YWHAG—uterine cervix—ovarian cancer	0.000177	0.011	CbGeAlD
Daunorubicin—POR—myometrium—ovarian cancer	0.000173	0.0107	CbGeAlD
Daunorubicin—XDH—uterine cervix—ovarian cancer	0.000173	0.0107	CbGeAlD
Daunorubicin—TOP2B—uterine cervix—ovarian cancer	0.000171	0.0106	CbGeAlD
Daunorubicin—YWHAG—decidua—ovarian cancer	0.000169	0.0105	CbGeAlD
Daunorubicin—TOP2B—decidua—ovarian cancer	0.000163	0.0101	CbGeAlD
Daunorubicin—NR5A1—testis—ovarian cancer	0.000162	0.01	CbGeAlD
Daunorubicin—TOP2A—myometrium—ovarian cancer	0.000161	0.01	CbGeAlD
Daunorubicin—YWHAG—endometrium—ovarian cancer	0.00016	0.00993	CbGeAlD
Daunorubicin—XDH—endometrium—ovarian cancer	0.000156	0.00968	CbGeAlD
Daunorubicin—TOP2B—endometrium—ovarian cancer	0.000154	0.00957	CbGeAlD
Daunorubicin—YWHAG—gonad—ovarian cancer	0.000149	0.00921	CbGeAlD
Daunorubicin—YWHAG—uterus—ovarian cancer	0.000148	0.00915	CbGeAlD
Daunorubicin—Doxorubicin—CYP1B1—ovarian cancer	0.000146	0.777	CrCbGaD
Daunorubicin—TOP2B—gonad—ovarian cancer	0.000143	0.00888	CbGeAlD
Daunorubicin—TOP2B—uterus—ovarian cancer	0.000142	0.00882	CbGeAlD
Daunorubicin—ABCC10—myometrium—ovarian cancer	0.000137	0.00851	CbGeAlD
Daunorubicin—POR—uterine cervix—ovarian cancer	0.000135	0.00835	CbGeAlD
Daunorubicin—TOP2A—Docetaxel—Paclitaxel—ovarian cancer	0.000134	0.235	CbGdCrCtD
Daunorubicin—YWHAG—female reproductive system—ovarian cancer	0.000133	0.00823	CbGeAlD
Daunorubicin—XDH—female reproductive system—ovarian cancer	0.000129	0.00802	CbGeAlD
Daunorubicin—POR—decidua—ovarian cancer	0.000128	0.00795	CbGeAlD
Daunorubicin—TOP2B—female reproductive system—ovarian cancer	0.000128	0.00793	CbGeAlD
Daunorubicin—TOP2A—uterine cervix—ovarian cancer	0.000126	0.00778	CbGeAlD
Daunorubicin—YWHAG—bone marrow—ovarian cancer	0.000125	0.00777	CbGeAlD
Daunorubicin—POR—endometrium—ovarian cancer	0.000122	0.00755	CbGeAlD
Daunorubicin—YWHAG—female gonad—ovarian cancer	0.000121	0.00748	CbGeAlD
Daunorubicin—TOP2B—bone marrow—ovarian cancer	0.000121	0.00748	CbGeAlD
Daunorubicin—YWHAG—vagina—ovarian cancer	0.00012	0.00744	CbGeAlD
Daunorubicin—TOP2A—decidua—ovarian cancer	0.00012	0.00741	CbGeAlD
Daunorubicin—XDH—vagina—ovarian cancer	0.000117	0.00726	CbGeAlD
Daunorubicin—TOP2B—female gonad—ovarian cancer	0.000116	0.00721	CbGeAlD
Daunorubicin—TOP2B—vagina—ovarian cancer	0.000116	0.00717	CbGeAlD
Daunorubicin—TOP2A—Irinotecan—Topotecan—ovarian cancer	0.000115	0.201	CbGdCrCtD
Daunorubicin—TOP2A—endometrium—ovarian cancer	0.000114	0.00704	CbGeAlD
Daunorubicin—YWHAG—testis—ovarian cancer	0.000107	0.00664	CbGeAlD
Daunorubicin—ABCC10—uterine cervix—ovarian cancer	0.000107	0.00662	CbGeAlD
Daunorubicin—TOP2A—uterus—ovarian cancer	0.000105	0.00648	CbGeAlD
Daunorubicin—TOP2B—testis—ovarian cancer	0.000103	0.0064	CbGeAlD
Daunorubicin—ABCB11—testis—ovarian cancer	0.000102	0.00632	CbGeAlD
Daunorubicin—ABCC10—decidua—ovarian cancer	0.000102	0.00631	CbGeAlD
Daunorubicin—ABCC1—myometrium—ovarian cancer	9.72e-05	0.00602	CbGeAlD
Daunorubicin—ABCC10—endometrium—ovarian cancer	9.67e-05	0.00599	CbGeAlD
Daunorubicin—POR—bone marrow—ovarian cancer	9.53e-05	0.0059	CbGeAlD
Daunorubicin—POR—female gonad—ovarian cancer	9.19e-05	0.00569	CbGeAlD
Daunorubicin—POR—vagina—ovarian cancer	9.13e-05	0.00566	CbGeAlD
Daunorubicin—ABCC10—gonad—ovarian cancer	8.97e-05	0.00556	CbGeAlD
Daunorubicin—ABCC10—uterus—ovarian cancer	8.91e-05	0.00552	CbGeAlD
Daunorubicin—TOP2A—bone marrow—ovarian cancer	8.88e-05	0.0055	CbGeAlD
Daunorubicin—TOP2A—female gonad—ovarian cancer	8.56e-05	0.0053	CbGeAlD
Daunorubicin—TOP2A—Vindesine—Vinorelbine—ovarian cancer	8.52e-05	0.15	CbGdCrCtD
Daunorubicin—TOP2A—vagina—ovarian cancer	8.51e-05	0.00527	CbGeAlD
Daunorubicin—POR—testis—ovarian cancer	8.15e-05	0.00505	CbGeAlD
Daunorubicin—ABCG2—myometrium—ovarian cancer	8.04e-05	0.00498	CbGeAlD
Daunorubicin—ABCC10—female reproductive system—ovarian cancer	8.01e-05	0.00496	CbGeAlD
Daunorubicin—CYP1B1—decidua—ovarian cancer	8.01e-05	0.00496	CbGeAlD
Daunorubicin—YWHAG—lymph node—ovarian cancer	7.77e-05	0.00481	CbGeAlD
Daunorubicin—TOP2A—testis—ovarian cancer	7.59e-05	0.0047	CbGeAlD
Daunorubicin—ABCC10—bone marrow—ovarian cancer	7.56e-05	0.00468	CbGeAlD
Daunorubicin—ABCC1—uterine cervix—ovarian cancer	7.56e-05	0.00468	CbGeAlD
Daunorubicin—TOP2B—lymph node—ovarian cancer	7.49e-05	0.00464	CbGeAlD
Daunorubicin—ABCC10—female gonad—ovarian cancer	7.29e-05	0.00452	CbGeAlD
Daunorubicin—ABCC10—vagina—ovarian cancer	7.24e-05	0.00449	CbGeAlD
Daunorubicin—ABCC1—decidua—ovarian cancer	7.2e-05	0.00446	CbGeAlD
Daunorubicin—CYP1B1—gonad—ovarian cancer	7.05e-05	0.00437	CbGeAlD
Daunorubicin—CYP1B1—uterus—ovarian cancer	7.01e-05	0.00434	CbGeAlD
Daunorubicin—ABCC1—endometrium—ovarian cancer	6.84e-05	0.00424	CbGeAlD
Daunorubicin—TOP2A—Paclitaxel—Docetaxel—ovarian cancer	6.69e-05	0.117	CbGdCrCtD
Daunorubicin—ABCC10—testis—ovarian cancer	6.46e-05	0.004	CbGeAlD
Daunorubicin—ABCC2—female reproductive system—ovarian cancer	6.43e-05	0.00398	CbGeAlD
Daunorubicin—ABCC1—uterus—ovarian cancer	6.3e-05	0.0039	CbGeAlD
Daunorubicin—CYP1B1—female reproductive system—ovarian cancer	6.3e-05	0.0039	CbGeAlD
Daunorubicin—ABCG2—uterine cervix—ovarian cancer	6.26e-05	0.00388	CbGeAlD
Daunorubicin—CYP1A1—epithelium—ovarian cancer	5.99e-05	0.00371	CbGeAlD
Daunorubicin—ABCG2—decidua—ovarian cancer	5.96e-05	0.00369	CbGeAlD
Daunorubicin—CYP1A1—uterine cervix—ovarian cancer	5.94e-05	0.00368	CbGeAlD
Daunorubicin—POR—lymph node—ovarian cancer	5.91e-05	0.00366	CbGeAlD
Daunorubicin—CYP3A5—uterine cervix—ovarian cancer	5.81e-05	0.0036	CbGeAlD
Daunorubicin—CYP1B1—female gonad—ovarian cancer	5.73e-05	0.00355	CbGeAlD
Daunorubicin—ABCG2—endometrium—ovarian cancer	5.66e-05	0.00351	CbGeAlD
Daunorubicin—TOP2A—lymph node—ovarian cancer	5.5e-05	0.00341	CbGeAlD
Daunorubicin—ABCG2—uterus—ovarian cancer	5.22e-05	0.00323	CbGeAlD
Daunorubicin—ABCC2—testis—ovarian cancer	5.19e-05	0.00322	CbGeAlD
Daunorubicin—ABCC1—female gonad—ovarian cancer	5.15e-05	0.00319	CbGeAlD
Daunorubicin—ABCC1—vagina—ovarian cancer	5.12e-05	0.00317	CbGeAlD
Daunorubicin—CYP1B1—testis—ovarian cancer	5.08e-05	0.00315	CbGeAlD
Daunorubicin—CYP1A1—uterus—ovarian cancer	4.95e-05	0.00307	CbGeAlD
Daunorubicin—ABCC10—lymph node—ovarian cancer	4.69e-05	0.0029	CbGeAlD
Daunorubicin—TOP2A—Vincristine—Vinorelbine—ovarian cancer	4.6e-05	0.0807	CbGdCrCtD
Daunorubicin—ABCC1—testis—ovarian cancer	4.57e-05	0.00283	CbGeAlD
Daunorubicin—CYP1A1—female reproductive system—ovarian cancer	4.45e-05	0.00276	CbGeAlD
Daunorubicin—ABCG2—bone marrow—ovarian cancer	4.43e-05	0.00274	CbGeAlD
Daunorubicin—ABCG2—female gonad—ovarian cancer	4.27e-05	0.00264	CbGeAlD
Daunorubicin—ABCG2—vagina—ovarian cancer	4.24e-05	0.00263	CbGeAlD
Daunorubicin—Doxorubicin—ABCB1—ovarian cancer	4.19e-05	0.223	CrCbGaD
Daunorubicin—CYP1A1—female gonad—ovarian cancer	4.05e-05	0.00251	CbGeAlD
Daunorubicin—CYP1A1—vagina—ovarian cancer	4.03e-05	0.00249	CbGeAlD
Daunorubicin—ABCB1—myometrium—ovarian cancer	3.97e-05	0.00246	CbGeAlD
Daunorubicin—CYP3A5—female gonad—ovarian cancer	3.96e-05	0.00245	CbGeAlD
Daunorubicin—CYP3A5—vagina—ovarian cancer	3.94e-05	0.00244	CbGeAlD
Daunorubicin—ABCB1—embryo—ovarian cancer	3.82e-05	0.00236	CbGeAlD
Daunorubicin—ABCG2—testis—ovarian cancer	3.79e-05	0.00234	CbGeAlD
Daunorubicin—ABCC2—lymph node—ovarian cancer	3.76e-05	0.00233	CbGeAlD
Daunorubicin—TOP2A—Vinblastine—Vinorelbine—ovarian cancer	3.7e-05	0.0649	CbGdCrCtD
Daunorubicin—CYP1B1—lymph node—ovarian cancer	3.68e-05	0.00228	CbGeAlD
Daunorubicin—ABCC1—lymph node—ovarian cancer	3.31e-05	0.00205	CbGeAlD
Daunorubicin—CYP3A4—female reproductive system—ovarian cancer	3.27e-05	0.00202	CbGeAlD
Daunorubicin—ABCB1—epithelium—ovarian cancer	3.11e-05	0.00193	CbGeAlD
Daunorubicin—ABCB1—uterine cervix—ovarian cancer	3.09e-05	0.00191	CbGeAlD
Daunorubicin—ABCB1—decidua—ovarian cancer	2.94e-05	0.00182	CbGeAlD
Daunorubicin—ABCB1—endometrium—ovarian cancer	2.79e-05	0.00173	CbGeAlD
Daunorubicin—ABCG2—lymph node—ovarian cancer	2.74e-05	0.0017	CbGeAlD
Daunorubicin—CYP1A1—lymph node—ovarian cancer	2.6e-05	0.00161	CbGeAlD
Daunorubicin—ABCB1—gonad—ovarian cancer	2.59e-05	0.0016	CbGeAlD
Daunorubicin—ABCB1—uterus—ovarian cancer	2.57e-05	0.00159	CbGeAlD
Daunorubicin—ABCB1—female reproductive system—ovarian cancer	2.31e-05	0.00143	CbGeAlD
Daunorubicin—TOP2A—Doxorubicin—Epirubicin—ovarian cancer	2.24e-05	0.0393	CbGdCrCtD
Daunorubicin—TOP2A—Idarubicin—Epirubicin—ovarian cancer	2.24e-05	0.0393	CbGdCrCtD
Daunorubicin—ABCB1—bone marrow—ovarian cancer	2.18e-05	0.00135	CbGeAlD
Daunorubicin—ABCB1—female gonad—ovarian cancer	2.1e-05	0.0013	CbGeAlD
Daunorubicin—ABCB1—vagina—ovarian cancer	2.09e-05	0.0013	CbGeAlD
Daunorubicin—TOP2A—Idarubicin—Doxorubicin—ovarian cancer	2.07e-05	0.0364	CbGdCrCtD
Daunorubicin—TOP2A—Epirubicin—Doxorubicin—ovarian cancer	2.07e-05	0.0364	CbGdCrCtD
Daunorubicin—ABCB1—testis—ovarian cancer	1.87e-05	0.00116	CbGeAlD
Daunorubicin—Dermatitis—Melphalan—ovarian cancer	1.82e-05	0.000617	CcSEcCtD
Daunorubicin—Chills—Docetaxel—ovarian cancer	1.82e-05	0.000616	CcSEcCtD
Daunorubicin—Cough—Paclitaxel—ovarian cancer	1.81e-05	0.000615	CcSEcCtD
Daunorubicin—Asthenia—Vinorelbine—ovarian cancer	1.81e-05	0.000613	CcSEcCtD
Daunorubicin—Dry skin—Epirubicin—ovarian cancer	1.81e-05	0.000613	CcSEcCtD
Daunorubicin—Arrhythmia—Docetaxel—ovarian cancer	1.81e-05	0.000613	CcSEcCtD
Daunorubicin—Convulsion—Paclitaxel—ovarian cancer	1.8e-05	0.000611	CcSEcCtD
Daunorubicin—Affect lability—Doxorubicin—ovarian cancer	1.8e-05	0.000609	CcSEcCtD
Daunorubicin—Hypertension—Paclitaxel—ovarian cancer	1.8e-05	0.000608	CcSEcCtD
Daunorubicin—Alopecia—Docetaxel—ovarian cancer	1.79e-05	0.000606	CcSEcCtD
Daunorubicin—Pruritus—Vinorelbine—ovarian cancer	1.79e-05	0.000605	CcSEcCtD
Daunorubicin—Chest pain—Paclitaxel—ovarian cancer	1.77e-05	0.0006	CcSEcCtD
Daunorubicin—Arthralgia—Paclitaxel—ovarian cancer	1.77e-05	0.0006	CcSEcCtD
Daunorubicin—Myalgia—Paclitaxel—ovarian cancer	1.77e-05	0.0006	CcSEcCtD
Daunorubicin—Anxiety—Paclitaxel—ovarian cancer	1.76e-05	0.000598	CcSEcCtD
Daunorubicin—Erythema—Docetaxel—ovarian cancer	1.76e-05	0.000597	CcSEcCtD
Daunorubicin—Nausea—Topotecan—ovarian cancer	1.75e-05	0.000594	CcSEcCtD
Daunorubicin—Discomfort—Paclitaxel—ovarian cancer	1.75e-05	0.000593	CcSEcCtD
Daunorubicin—Gastritis—Epirubicin—ovarian cancer	1.75e-05	0.000592	CcSEcCtD
Daunorubicin—Cardiac arrest—Doxorubicin—ovarian cancer	1.74e-05	0.000589	CcSEcCtD
Daunorubicin—Dry mouth—Paclitaxel—ovarian cancer	1.73e-05	0.000587	CcSEcCtD
Daunorubicin—Mood swings—Doxorubicin—ovarian cancer	1.73e-05	0.000586	CcSEcCtD
Daunorubicin—Diarrhoea—Vinorelbine—ovarian cancer	1.73e-05	0.000585	CcSEcCtD
Daunorubicin—Dysgeusia—Docetaxel—ovarian cancer	1.73e-05	0.000585	CcSEcCtD
Daunorubicin—Ataxia—Doxorubicin—ovarian cancer	1.72e-05	0.000582	CcSEcCtD
Daunorubicin—Nausea—Melphalan—ovarian cancer	1.72e-05	0.000581	CcSEcCtD
Daunorubicin—Confusional state—Paclitaxel—ovarian cancer	1.71e-05	0.00058	CcSEcCtD
Daunorubicin—Dysphagia—Epirubicin—ovarian cancer	1.71e-05	0.000578	CcSEcCtD
Daunorubicin—Back pain—Docetaxel—ovarian cancer	1.71e-05	0.000578	CcSEcCtD
Daunorubicin—Dehydration—Doxorubicin—ovarian cancer	1.7e-05	0.000576	CcSEcCtD
Daunorubicin—Anaphylactic shock—Paclitaxel—ovarian cancer	1.7e-05	0.000575	CcSEcCtD
Daunorubicin—Oedema—Paclitaxel—ovarian cancer	1.7e-05	0.000575	CcSEcCtD
Daunorubicin—Infection—Paclitaxel—ovarian cancer	1.69e-05	0.000571	CcSEcCtD
Daunorubicin—Dry skin—Doxorubicin—ovarian cancer	1.67e-05	0.000567	CcSEcCtD
Daunorubicin—Shock—Paclitaxel—ovarian cancer	1.67e-05	0.000566	CcSEcCtD
Daunorubicin—Dizziness—Vinorelbine—ovarian cancer	1.67e-05	0.000565	CcSEcCtD
Daunorubicin—Angina pectoris—Epirubicin—ovarian cancer	1.66e-05	0.000563	CcSEcCtD
Daunorubicin—Thrombocytopenia—Paclitaxel—ovarian cancer	1.66e-05	0.000563	CcSEcCtD
Daunorubicin—Tachycardia—Paclitaxel—ovarian cancer	1.66e-05	0.000561	CcSEcCtD
Daunorubicin—Hyperhidrosis—Paclitaxel—ovarian cancer	1.64e-05	0.000556	CcSEcCtD
Daunorubicin—Anaemia—Docetaxel—ovarian cancer	1.63e-05	0.000552	CcSEcCtD
Daunorubicin—Pancytopenia—Epirubicin—ovarian cancer	1.62e-05	0.000549	CcSEcCtD
Daunorubicin—Anorexia—Paclitaxel—ovarian cancer	1.62e-05	0.000548	CcSEcCtD
Daunorubicin—Gastritis—Doxorubicin—ovarian cancer	1.62e-05	0.000548	CcSEcCtD
Daunorubicin—Vomiting—Vinorelbine—ovarian cancer	1.6e-05	0.000544	CcSEcCtD
Daunorubicin—Neutropenia—Epirubicin—ovarian cancer	1.6e-05	0.000541	CcSEcCtD
Daunorubicin—Dysuria—Epirubicin—ovarian cancer	1.6e-05	0.000541	CcSEcCtD
Daunorubicin—Rash—Vinorelbine—ovarian cancer	1.59e-05	0.000539	CcSEcCtD
Daunorubicin—Dermatitis—Vinorelbine—ovarian cancer	1.59e-05	0.000539	CcSEcCtD
Daunorubicin—Headache—Vinorelbine—ovarian cancer	1.58e-05	0.000536	CcSEcCtD
Daunorubicin—Syncope—Docetaxel—ovarian cancer	1.58e-05	0.000536	CcSEcCtD
Daunorubicin—Dysphagia—Doxorubicin—ovarian cancer	1.58e-05	0.000535	CcSEcCtD
Daunorubicin—Leukopenia—Docetaxel—ovarian cancer	1.58e-05	0.000535	CcSEcCtD
Daunorubicin—Palpitations—Docetaxel—ovarian cancer	1.56e-05	0.000528	CcSEcCtD
Daunorubicin—Loss of consciousness—Docetaxel—ovarian cancer	1.55e-05	0.000525	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	1.55e-05	0.000524	CcSEcCtD
Daunorubicin—Cough—Docetaxel—ovarian cancer	1.54e-05	0.000521	CcSEcCtD
Daunorubicin—Angina pectoris—Doxorubicin—ovarian cancer	1.54e-05	0.000521	CcSEcCtD
Daunorubicin—Insomnia—Paclitaxel—ovarian cancer	1.54e-05	0.00052	CcSEcCtD
Daunorubicin—Convulsion—Docetaxel—ovarian cancer	1.53e-05	0.000517	CcSEcCtD
Daunorubicin—Hypertension—Docetaxel—ovarian cancer	1.52e-05	0.000516	CcSEcCtD
Daunorubicin—Dyspnoea—Paclitaxel—ovarian cancer	1.51e-05	0.000513	CcSEcCtD
Daunorubicin—Somnolence—Paclitaxel—ovarian cancer	1.51e-05	0.000511	CcSEcCtD
Daunorubicin—Arthralgia—Docetaxel—ovarian cancer	1.5e-05	0.000508	CcSEcCtD
Daunorubicin—Myalgia—Docetaxel—ovarian cancer	1.5e-05	0.000508	CcSEcCtD
Daunorubicin—Chest pain—Docetaxel—ovarian cancer	1.5e-05	0.000508	CcSEcCtD
Daunorubicin—Pancytopenia—Doxorubicin—ovarian cancer	1.5e-05	0.000508	CcSEcCtD
Daunorubicin—Nausea—Vinorelbine—ovarian cancer	1.5e-05	0.000508	CcSEcCtD
Daunorubicin—Renal failure—Epirubicin—ovarian cancer	1.5e-05	0.000507	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Epirubicin—ovarian cancer	1.49e-05	0.000505	CcSEcCtD
Daunorubicin—Stomatitis—Epirubicin—ovarian cancer	1.48e-05	0.000503	CcSEcCtD
Daunorubicin—Conjunctivitis—Epirubicin—ovarian cancer	1.48e-05	0.000501	CcSEcCtD
Daunorubicin—Dysuria—Doxorubicin—ovarian cancer	1.48e-05	0.0005	CcSEcCtD
Daunorubicin—Neutropenia—Doxorubicin—ovarian cancer	1.48e-05	0.0005	CcSEcCtD
Daunorubicin—Decreased appetite—Paclitaxel—ovarian cancer	1.48e-05	0.0005	CcSEcCtD
Daunorubicin—Dry mouth—Docetaxel—ovarian cancer	1.47e-05	0.000497	CcSEcCtD
Daunorubicin—Fatigue—Paclitaxel—ovarian cancer	1.46e-05	0.000496	CcSEcCtD
Daunorubicin—Pain—Paclitaxel—ovarian cancer	1.45e-05	0.000492	CcSEcCtD
Daunorubicin—Constipation—Paclitaxel—ovarian cancer	1.45e-05	0.000492	CcSEcCtD
Daunorubicin—Confusional state—Docetaxel—ovarian cancer	1.45e-05	0.000492	CcSEcCtD
Daunorubicin—Anaphylactic shock—Docetaxel—ovarian cancer	1.44e-05	0.000487	CcSEcCtD
Daunorubicin—Oedema—Docetaxel—ovarian cancer	1.44e-05	0.000487	CcSEcCtD
Daunorubicin—Infection—Docetaxel—ovarian cancer	1.43e-05	0.000484	CcSEcCtD
Daunorubicin—Sinusitis—Epirubicin—ovarian cancer	1.43e-05	0.000484	CcSEcCtD
Daunorubicin—Shock—Docetaxel—ovarian cancer	1.42e-05	0.00048	CcSEcCtD
Daunorubicin—Thrombocytopenia—Docetaxel—ovarian cancer	1.41e-05	0.000477	CcSEcCtD
Daunorubicin—Tachycardia—Docetaxel—ovarian cancer	1.4e-05	0.000476	CcSEcCtD
Daunorubicin—Feeling abnormal—Paclitaxel—ovarian cancer	1.4e-05	0.000474	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Paclitaxel—ovarian cancer	1.39e-05	0.00047	CcSEcCtD
Daunorubicin—Renal failure—Doxorubicin—ovarian cancer	1.38e-05	0.000469	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Doxorubicin—ovarian cancer	1.38e-05	0.000468	CcSEcCtD
Daunorubicin—Stomatitis—Doxorubicin—ovarian cancer	1.37e-05	0.000465	CcSEcCtD
Daunorubicin—Anorexia—Docetaxel—ovarian cancer	1.37e-05	0.000465	CcSEcCtD
Daunorubicin—Rhinitis—Epirubicin—ovarian cancer	1.37e-05	0.000464	CcSEcCtD
Daunorubicin—Conjunctivitis—Doxorubicin—ovarian cancer	1.37e-05	0.000464	CcSEcCtD
Daunorubicin—ABCB1—lymph node—ovarian cancer	1.35e-05	0.000838	CbGeAlD
Daunorubicin—Urticaria—Paclitaxel—ovarian cancer	1.35e-05	0.000457	CcSEcCtD
Daunorubicin—Abdominal pain—Paclitaxel—ovarian cancer	1.34e-05	0.000455	CcSEcCtD
Daunorubicin—Body temperature increased—Paclitaxel—ovarian cancer	1.34e-05	0.000455	CcSEcCtD
Daunorubicin—Sinusitis—Doxorubicin—ovarian cancer	1.32e-05	0.000448	CcSEcCtD
Daunorubicin—Visual impairment—Epirubicin—ovarian cancer	1.32e-05	0.000446	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	1.31e-05	0.000444	CcSEcCtD
Daunorubicin—Insomnia—Docetaxel—ovarian cancer	1.3e-05	0.000441	CcSEcCtD
Daunorubicin—Dyspnoea—Docetaxel—ovarian cancer	1.28e-05	0.000435	CcSEcCtD
Daunorubicin—Somnolence—Docetaxel—ovarian cancer	1.28e-05	0.000433	CcSEcCtD
Daunorubicin—Tinnitus—Epirubicin—ovarian cancer	1.27e-05	0.000431	CcSEcCtD
Daunorubicin—Cardiac disorder—Epirubicin—ovarian cancer	1.27e-05	0.00043	CcSEcCtD
Daunorubicin—Flushing—Epirubicin—ovarian cancer	1.27e-05	0.00043	CcSEcCtD
Daunorubicin—Rhinitis—Doxorubicin—ovarian cancer	1.27e-05	0.000429	CcSEcCtD
Daunorubicin—Decreased appetite—Docetaxel—ovarian cancer	1.25e-05	0.000424	CcSEcCtD
Daunorubicin—Hypersensitivity—Paclitaxel—ovarian cancer	1.25e-05	0.000424	CcSEcCtD
Daunorubicin—Fatigue—Docetaxel—ovarian cancer	1.24e-05	0.00042	CcSEcCtD
Daunorubicin—Pain—Docetaxel—ovarian cancer	1.23e-05	0.000417	CcSEcCtD
Daunorubicin—Constipation—Docetaxel—ovarian cancer	1.23e-05	0.000417	CcSEcCtD
Daunorubicin—Chills—Epirubicin—ovarian cancer	1.23e-05	0.000415	CcSEcCtD
Daunorubicin—Arrhythmia—Epirubicin—ovarian cancer	1.22e-05	0.000413	CcSEcCtD
Daunorubicin—Visual impairment—Doxorubicin—ovarian cancer	1.22e-05	0.000413	CcSEcCtD
Daunorubicin—Asthenia—Paclitaxel—ovarian cancer	1.22e-05	0.000413	CcSEcCtD
Daunorubicin—Alopecia—Epirubicin—ovarian cancer	1.21e-05	0.000409	CcSEcCtD
Daunorubicin—Pruritus—Paclitaxel—ovarian cancer	1.2e-05	0.000407	CcSEcCtD
Daunorubicin—Erythema—Epirubicin—ovarian cancer	1.19e-05	0.000403	CcSEcCtD
Daunorubicin—Feeling abnormal—Docetaxel—ovarian cancer	1.19e-05	0.000402	CcSEcCtD
Daunorubicin—Tinnitus—Doxorubicin—ovarian cancer	1.18e-05	0.000399	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Docetaxel—ovarian cancer	1.18e-05	0.000399	CcSEcCtD
Daunorubicin—Flushing—Doxorubicin—ovarian cancer	1.17e-05	0.000397	CcSEcCtD
Daunorubicin—Cardiac disorder—Doxorubicin—ovarian cancer	1.17e-05	0.000397	CcSEcCtD
Daunorubicin—Dysgeusia—Epirubicin—ovarian cancer	1.16e-05	0.000395	CcSEcCtD
Daunorubicin—Diarrhoea—Paclitaxel—ovarian cancer	1.16e-05	0.000393	CcSEcCtD
Daunorubicin—Back pain—Epirubicin—ovarian cancer	1.15e-05	0.00039	CcSEcCtD
Daunorubicin—Abdominal pain—Docetaxel—ovarian cancer	1.14e-05	0.000385	CcSEcCtD
Daunorubicin—Body temperature increased—Docetaxel—ovarian cancer	1.14e-05	0.000385	CcSEcCtD
Daunorubicin—Chills—Doxorubicin—ovarian cancer	1.13e-05	0.000384	CcSEcCtD
Daunorubicin—Arrhythmia—Doxorubicin—ovarian cancer	1.13e-05	0.000383	CcSEcCtD
Daunorubicin—Dizziness—Paclitaxel—ovarian cancer	1.12e-05	0.00038	CcSEcCtD
Daunorubicin—Alopecia—Doxorubicin—ovarian cancer	1.12e-05	0.000378	CcSEcCtD
Daunorubicin—Ill-defined disorder—Epirubicin—ovarian cancer	1.1e-05	0.000374	CcSEcCtD
Daunorubicin—Erythema—Doxorubicin—ovarian cancer	1.1e-05	0.000373	CcSEcCtD
Daunorubicin—Anaemia—Epirubicin—ovarian cancer	1.1e-05	0.000372	CcSEcCtD
Daunorubicin—Agitation—Epirubicin—ovarian cancer	1.09e-05	0.00037	CcSEcCtD
Daunorubicin—Vomiting—Paclitaxel—ovarian cancer	1.08e-05	0.000366	CcSEcCtD
Daunorubicin—Dysgeusia—Doxorubicin—ovarian cancer	1.08e-05	0.000365	CcSEcCtD
Daunorubicin—Malaise—Epirubicin—ovarian cancer	1.07e-05	0.000363	CcSEcCtD
Daunorubicin—Rash—Paclitaxel—ovarian cancer	1.07e-05	0.000363	CcSEcCtD
Daunorubicin—Dermatitis—Paclitaxel—ovarian cancer	1.07e-05	0.000362	CcSEcCtD
Daunorubicin—Syncope—Epirubicin—ovarian cancer	1.07e-05	0.000361	CcSEcCtD
Daunorubicin—Leukopenia—Epirubicin—ovarian cancer	1.06e-05	0.000361	CcSEcCtD
Daunorubicin—Back pain—Doxorubicin—ovarian cancer	1.06e-05	0.000361	CcSEcCtD
Daunorubicin—Headache—Paclitaxel—ovarian cancer	1.06e-05	0.00036	CcSEcCtD
Daunorubicin—Hypersensitivity—Docetaxel—ovarian cancer	1.06e-05	0.000359	CcSEcCtD
Daunorubicin—Palpitations—Epirubicin—ovarian cancer	1.05e-05	0.000356	CcSEcCtD
Daunorubicin—Loss of consciousness—Epirubicin—ovarian cancer	1.05e-05	0.000354	CcSEcCtD
Daunorubicin—Cough—Epirubicin—ovarian cancer	1.04e-05	0.000352	CcSEcCtD
Daunorubicin—Asthenia—Docetaxel—ovarian cancer	1.03e-05	0.00035	CcSEcCtD
Daunorubicin—Convulsion—Epirubicin—ovarian cancer	1.03e-05	0.000349	CcSEcCtD
Daunorubicin—Hypertension—Epirubicin—ovarian cancer	1.03e-05	0.000348	CcSEcCtD
Daunorubicin—Ill-defined disorder—Doxorubicin—ovarian cancer	1.02e-05	0.000346	CcSEcCtD
Daunorubicin—Pruritus—Docetaxel—ovarian cancer	1.02e-05	0.000345	CcSEcCtD
Daunorubicin—Anaemia—Doxorubicin—ovarian cancer	1.02e-05	0.000345	CcSEcCtD
Daunorubicin—Arthralgia—Epirubicin—ovarian cancer	1.01e-05	0.000343	CcSEcCtD
Daunorubicin—Chest pain—Epirubicin—ovarian cancer	1.01e-05	0.000343	CcSEcCtD
Daunorubicin—Myalgia—Epirubicin—ovarian cancer	1.01e-05	0.000343	CcSEcCtD
Daunorubicin—Agitation—Doxorubicin—ovarian cancer	1.01e-05	0.000343	CcSEcCtD
Daunorubicin—Anxiety—Epirubicin—ovarian cancer	1.01e-05	0.000342	CcSEcCtD
Daunorubicin—Nausea—Paclitaxel—ovarian cancer	1.01e-05	0.000342	CcSEcCtD
Daunorubicin—Discomfort—Epirubicin—ovarian cancer	1e-05	0.000339	CcSEcCtD
Daunorubicin—Malaise—Doxorubicin—ovarian cancer	9.92e-06	0.000336	CcSEcCtD
Daunorubicin—Dry mouth—Epirubicin—ovarian cancer	9.9e-06	0.000335	CcSEcCtD
Daunorubicin—Syncope—Doxorubicin—ovarian cancer	9.87e-06	0.000334	CcSEcCtD
Daunorubicin—Leukopenia—Doxorubicin—ovarian cancer	9.85e-06	0.000334	CcSEcCtD
Daunorubicin—Diarrhoea—Docetaxel—ovarian cancer	9.84e-06	0.000334	CcSEcCtD
Daunorubicin—Confusional state—Epirubicin—ovarian cancer	9.78e-06	0.000332	CcSEcCtD
Daunorubicin—Palpitations—Doxorubicin—ovarian cancer	9.72e-06	0.000329	CcSEcCtD
Daunorubicin—Anaphylactic shock—Epirubicin—ovarian cancer	9.7e-06	0.000329	CcSEcCtD
Daunorubicin—Oedema—Epirubicin—ovarian cancer	9.7e-06	0.000329	CcSEcCtD
Daunorubicin—Loss of consciousness—Doxorubicin—ovarian cancer	9.67e-06	0.000328	CcSEcCtD
Daunorubicin—Infection—Epirubicin—ovarian cancer	9.64e-06	0.000327	CcSEcCtD
Daunorubicin—Cough—Doxorubicin—ovarian cancer	9.6e-06	0.000325	CcSEcCtD
Daunorubicin—Shock—Epirubicin—ovarian cancer	9.55e-06	0.000323	CcSEcCtD
Daunorubicin—Convulsion—Doxorubicin—ovarian cancer	9.53e-06	0.000323	CcSEcCtD
Daunorubicin—Dizziness—Docetaxel—ovarian cancer	9.51e-06	0.000322	CcSEcCtD
Daunorubicin—Thrombocytopenia—Epirubicin—ovarian cancer	9.5e-06	0.000322	CcSEcCtD
Daunorubicin—Hypertension—Doxorubicin—ovarian cancer	9.5e-06	0.000322	CcSEcCtD
Daunorubicin—Tachycardia—Epirubicin—ovarian cancer	9.47e-06	0.000321	CcSEcCtD
Daunorubicin—Hyperhidrosis—Epirubicin—ovarian cancer	9.38e-06	0.000318	CcSEcCtD
Daunorubicin—Chest pain—Doxorubicin—ovarian cancer	9.37e-06	0.000317	CcSEcCtD
Daunorubicin—Myalgia—Doxorubicin—ovarian cancer	9.37e-06	0.000317	CcSEcCtD
Daunorubicin—Arthralgia—Doxorubicin—ovarian cancer	9.37e-06	0.000317	CcSEcCtD
Daunorubicin—Anxiety—Doxorubicin—ovarian cancer	9.33e-06	0.000316	CcSEcCtD
Daunorubicin—Discomfort—Doxorubicin—ovarian cancer	9.25e-06	0.000314	CcSEcCtD
Daunorubicin—Anorexia—Epirubicin—ovarian cancer	9.25e-06	0.000313	CcSEcCtD
Daunorubicin—Dry mouth—Doxorubicin—ovarian cancer	9.16e-06	0.00031	CcSEcCtD
Daunorubicin—Vomiting—Docetaxel—ovarian cancer	9.15e-06	0.00031	CcSEcCtD
Daunorubicin—Rash—Docetaxel—ovarian cancer	9.07e-06	0.000307	CcSEcCtD
Daunorubicin—Dermatitis—Docetaxel—ovarian cancer	9.06e-06	0.000307	CcSEcCtD
Daunorubicin—Confusional state—Doxorubicin—ovarian cancer	9.05e-06	0.000307	CcSEcCtD
Daunorubicin—Headache—Docetaxel—ovarian cancer	9.01e-06	0.000305	CcSEcCtD
Daunorubicin—Anaphylactic shock—Doxorubicin—ovarian cancer	8.98e-06	0.000304	CcSEcCtD
Daunorubicin—Oedema—Doxorubicin—ovarian cancer	8.98e-06	0.000304	CcSEcCtD
Daunorubicin—Infection—Doxorubicin—ovarian cancer	8.92e-06	0.000302	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	8.84e-06	0.0003	CcSEcCtD
Daunorubicin—Shock—Doxorubicin—ovarian cancer	8.83e-06	0.000299	CcSEcCtD
Daunorubicin—Thrombocytopenia—Doxorubicin—ovarian cancer	8.79e-06	0.000298	CcSEcCtD
Daunorubicin—Insomnia—Epirubicin—ovarian cancer	8.78e-06	0.000297	CcSEcCtD
Daunorubicin—Tachycardia—Doxorubicin—ovarian cancer	8.76e-06	0.000297	CcSEcCtD
Daunorubicin—Hyperhidrosis—Doxorubicin—ovarian cancer	8.68e-06	0.000294	CcSEcCtD
Daunorubicin—Dyspnoea—Epirubicin—ovarian cancer	8.65e-06	0.000293	CcSEcCtD
Daunorubicin—Somnolence—Epirubicin—ovarian cancer	8.63e-06	0.000292	CcSEcCtD
Daunorubicin—Anorexia—Doxorubicin—ovarian cancer	8.56e-06	0.00029	CcSEcCtD
Daunorubicin—Nausea—Docetaxel—ovarian cancer	8.55e-06	0.00029	CcSEcCtD
Daunorubicin—Decreased appetite—Epirubicin—ovarian cancer	8.44e-06	0.000286	CcSEcCtD
Daunorubicin—Fatigue—Epirubicin—ovarian cancer	8.37e-06	0.000283	CcSEcCtD
Daunorubicin—Pain—Epirubicin—ovarian cancer	8.3e-06	0.000281	CcSEcCtD
Daunorubicin—Constipation—Epirubicin—ovarian cancer	8.3e-06	0.000281	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	8.18e-06	0.000277	CcSEcCtD
Daunorubicin—Insomnia—Doxorubicin—ovarian cancer	8.12e-06	0.000275	CcSEcCtD
Daunorubicin—Dyspnoea—Doxorubicin—ovarian cancer	8e-06	0.000271	CcSEcCtD
Daunorubicin—Feeling abnormal—Epirubicin—ovarian cancer	8e-06	0.000271	CcSEcCtD
Daunorubicin—Somnolence—Doxorubicin—ovarian cancer	7.98e-06	0.00027	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Epirubicin—ovarian cancer	7.94e-06	0.000269	CcSEcCtD
Daunorubicin—Decreased appetite—Doxorubicin—ovarian cancer	7.81e-06	0.000264	CcSEcCtD
Daunorubicin—Fatigue—Doxorubicin—ovarian cancer	7.74e-06	0.000262	CcSEcCtD
Daunorubicin—Urticaria—Epirubicin—ovarian cancer	7.71e-06	0.000261	CcSEcCtD
Daunorubicin—Pain—Doxorubicin—ovarian cancer	7.68e-06	0.00026	CcSEcCtD
Daunorubicin—Constipation—Doxorubicin—ovarian cancer	7.68e-06	0.00026	CcSEcCtD
Daunorubicin—Body temperature increased—Epirubicin—ovarian cancer	7.67e-06	0.00026	CcSEcCtD
Daunorubicin—Abdominal pain—Epirubicin—ovarian cancer	7.67e-06	0.00026	CcSEcCtD
Daunorubicin—Feeling abnormal—Doxorubicin—ovarian cancer	7.4e-06	0.000251	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Doxorubicin—ovarian cancer	7.34e-06	0.000249	CcSEcCtD
Daunorubicin—Hypersensitivity—Epirubicin—ovarian cancer	7.15e-06	0.000242	CcSEcCtD
Daunorubicin—Urticaria—Doxorubicin—ovarian cancer	7.13e-06	0.000242	CcSEcCtD
Daunorubicin—Abdominal pain—Doxorubicin—ovarian cancer	7.1e-06	0.00024	CcSEcCtD
Daunorubicin—Body temperature increased—Doxorubicin—ovarian cancer	7.1e-06	0.00024	CcSEcCtD
Daunorubicin—Asthenia—Epirubicin—ovarian cancer	6.96e-06	0.000236	CcSEcCtD
Daunorubicin—Pruritus—Epirubicin—ovarian cancer	6.87e-06	0.000233	CcSEcCtD
Daunorubicin—Diarrhoea—Epirubicin—ovarian cancer	6.64e-06	0.000225	CcSEcCtD
Daunorubicin—Hypersensitivity—Doxorubicin—ovarian cancer	6.62e-06	0.000224	CcSEcCtD
Daunorubicin—Asthenia—Doxorubicin—ovarian cancer	6.44e-06	0.000218	CcSEcCtD
Daunorubicin—Dizziness—Epirubicin—ovarian cancer	6.42e-06	0.000217	CcSEcCtD
Daunorubicin—Pruritus—Doxorubicin—ovarian cancer	6.35e-06	0.000215	CcSEcCtD
Daunorubicin—Vomiting—Epirubicin—ovarian cancer	6.17e-06	0.000209	CcSEcCtD
Daunorubicin—Diarrhoea—Doxorubicin—ovarian cancer	6.14e-06	0.000208	CcSEcCtD
Daunorubicin—Rash—Epirubicin—ovarian cancer	6.12e-06	0.000207	CcSEcCtD
Daunorubicin—Dermatitis—Epirubicin—ovarian cancer	6.11e-06	0.000207	CcSEcCtD
Daunorubicin—Headache—Epirubicin—ovarian cancer	6.08e-06	0.000206	CcSEcCtD
Daunorubicin—Dizziness—Doxorubicin—ovarian cancer	5.94e-06	0.000201	CcSEcCtD
Daunorubicin—Nausea—Epirubicin—ovarian cancer	5.76e-06	0.000195	CcSEcCtD
Daunorubicin—Vomiting—Doxorubicin—ovarian cancer	5.71e-06	0.000193	CcSEcCtD
Daunorubicin—Rash—Doxorubicin—ovarian cancer	5.66e-06	0.000192	CcSEcCtD
Daunorubicin—Dermatitis—Doxorubicin—ovarian cancer	5.66e-06	0.000192	CcSEcCtD
Daunorubicin—Headache—Doxorubicin—ovarian cancer	5.62e-06	0.000191	CcSEcCtD
Daunorubicin—Nausea—Doxorubicin—ovarian cancer	5.33e-06	0.000181	CcSEcCtD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	2.78e-06	0.000217	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NME2—ovarian cancer	2.78e-06	0.000217	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—YAP1—ovarian cancer	2.77e-06	0.000216	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.75e-06	0.000214	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.74e-06	0.000213	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CYP1B1—ovarian cancer	2.73e-06	0.000213	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—FASN—ovarian cancer	2.69e-06	0.00021	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PARP1—ovarian cancer	2.68e-06	0.000209	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—YAP1—ovarian cancer	2.68e-06	0.000208	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—ovarian cancer	2.65e-06	0.000206	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.65e-06	0.000206	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—BRIP1—ovarian cancer	2.6e-06	0.000203	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPP1CC—ovarian cancer	2.6e-06	0.000203	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	2.59e-06	0.000202	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SLC2A1—ovarian cancer	2.56e-06	0.000199	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—MYC—ovarian cancer	2.52e-06	0.000197	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	2.47e-06	0.000192	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPP1CC—ovarian cancer	2.46e-06	0.000191	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—BRIP1—ovarian cancer	2.46e-06	0.000191	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—YAP1—ovarian cancer	2.43e-06	0.00019	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PPP2R1A—ovarian cancer	2.42e-06	0.000189	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	2.42e-06	0.000189	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—CAV1—ovarian cancer	2.42e-06	0.000188	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.41e-06	0.000188	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—YAP1—ovarian cancer	2.41e-06	0.000188	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.41e-06	0.000187	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.38e-06	0.000185	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.36e-06	0.000184	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.33e-06	0.000181	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MAPK3—ovarian cancer	2.32e-06	0.000181	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—MAPK1—ovarian cancer	2.27e-06	0.000177	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MYC—ovarian cancer	2.26e-06	0.000176	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—FASN—ovarian cancer	2.25e-06	0.000176	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.25e-06	0.000176	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ABCB1—ovarian cancer	2.25e-06	0.000175	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYTB—ovarian cancer	2.24e-06	0.000175	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	2.24e-06	0.000175	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—SLC5A5—ovarian cancer	2.22e-06	0.000173	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—AKT1—ovarian cancer	2.21e-06	0.000172	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—TYMS—ovarian cancer	2.21e-06	0.000172	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MAPK1—ovarian cancer	2.21e-06	0.000172	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CG—ovarian cancer	2.2e-06	0.000171	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	2.2e-06	0.000171	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—FASN—ovarian cancer	2.18e-06	0.00017	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.18e-06	0.00017	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PPP2R1A—ovarian cancer	2.17e-06	0.000169	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NME2—ovarian cancer	2.15e-06	0.000167	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—SLC5A5—ovarian cancer	2.15e-06	0.000167	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—SLC2A1—ovarian cancer	2.14e-06	0.000167	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	2.14e-06	0.000167	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	2.12e-06	0.000165	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.1e-06	0.000163	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—SLC2A1—ovarian cancer	2.07e-06	0.000161	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	2.06e-06	0.000161	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP1B1—ovarian cancer	2.05e-06	0.00016	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.03e-06	0.000158	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—FASN—ovarian cancer	1.98e-06	0.000155	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—FASN—ovarian cancer	1.96e-06	0.000153	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.96e-06	0.000153	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—BRIP1—ovarian cancer	1.96e-06	0.000153	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SLC5A5—ovarian cancer	1.95e-06	0.000152	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CD—ovarian cancer	1.94e-06	0.000151	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SLC5A5—ovarian cancer	1.93e-06	0.00015	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.92e-06	0.00015	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SLC2A1—ovarian cancer	1.88e-06	0.000147	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SLC2A1—ovarian cancer	1.87e-06	0.000145	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.87e-06	0.000145	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—ovarian cancer	1.85e-06	0.000144	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—HRAS—ovarian cancer	1.82e-06	0.000142	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PPP2R1A—ovarian cancer	1.82e-06	0.000142	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.81e-06	0.000141	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.81e-06	0.000141	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYTB—ovarian cancer	1.79e-06	0.00014	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.79e-06	0.000139	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP1B1—ovarian cancer	1.79e-06	0.000139	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CAV1—ovarian cancer	1.78e-06	0.000139	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.76e-06	0.000137	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PPP2R1A—ovarian cancer	1.76e-06	0.000137	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.75e-06	0.000137	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.75e-06	0.000136	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—YAP1—ovarian cancer	1.74e-06	0.000136	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TERT—ovarian cancer	1.73e-06	0.000135	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.72e-06	0.000134	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.7e-06	0.000133	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ABCB1—ovarian cancer	1.69e-06	0.000132	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CB—ovarian cancer	1.69e-06	0.000131	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.68e-06	0.000131	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.68e-06	0.000131	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—TYMS—ovarian cancer	1.66e-06	0.000129	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—YAP1—ovarian cancer	1.65e-06	0.000128	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ABCB1—ovarian cancer	1.64e-06	0.000127	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.63e-06	0.000127	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CG—ovarian cancer	1.62e-06	0.000126	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—TYMS—ovarian cancer	1.61e-06	0.000125	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PPP2R1A—ovarian cancer	1.6e-06	0.000125	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CAV1—ovarian cancer	1.6e-06	0.000125	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PPP2R1A—ovarian cancer	1.59e-06	0.000124	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.59e-06	0.000124	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.57e-06	0.000122	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.57e-06	0.000122	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IL6ST—ovarian cancer	1.51e-06	0.000118	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ABCB1—ovarian cancer	1.49e-06	0.000116	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ABCB1—ovarian cancer	1.47e-06	0.000115	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—TYMS—ovarian cancer	1.46e-06	0.000114	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTEN—ovarian cancer	1.46e-06	0.000114	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.46e-06	0.000113	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—APC—ovarian cancer	1.46e-06	0.000113	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—TYMS—ovarian cancer	1.45e-06	0.000113	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.43e-06	0.000112	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CD—ovarian cancer	1.43e-06	0.000111	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—FASN—ovarian cancer	1.42e-06	0.000111	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.41e-06	0.00011	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.4e-06	0.000109	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYTB—ovarian cancer	1.38e-06	0.000108	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.35e-06	0.000105	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—FASN—ovarian cancer	1.34e-06	0.000105	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CAV1—ovarian cancer	1.34e-06	0.000104	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SLC5A5—ovarian cancer	1.32e-06	0.000103	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—YAP1—ovarian cancer	1.32e-06	0.000103	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP1B1—ovarian cancer	1.29e-06	0.000101	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CAV1—ovarian cancer	1.29e-06	0.000101	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CD—ovarian cancer	1.28e-06	9.97e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.28e-06	9.96e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SLC2A1—ovarian cancer	1.28e-06	9.94e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.25e-06	9.73e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CB—ovarian cancer	1.24e-06	9.69e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.24e-06	9.64e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP1B1—ovarian cancer	1.22e-06	9.53e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CG—ovarian cancer	1.22e-06	9.5e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.21e-06	9.42e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.21e-06	9.42e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.19e-06	9.27e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CG—ovarian cancer	1.18e-06	9.19e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CAV1—ovarian cancer	1.18e-06	9.18e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CAV1—ovarian cancer	1.17e-06	9.08e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	1.15e-06	8.95e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.14e-06	8.89e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—ERBB2—ovarian cancer	1.13e-06	8.81e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CB—ovarian cancer	1.12e-06	8.69e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MTOR—ovarian cancer	1.12e-06	8.69e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	1.08e-06	8.45e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.08e-06	8.41e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTEN—ovarian cancer	1.07e-06	8.37e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CG—ovarian cancer	1.07e-06	8.36e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—FASN—ovarian cancer	1.07e-06	8.36e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CD—ovarian cancer	1.07e-06	8.35e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ABCB1—ovarian cancer	1.07e-06	8.31e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CG—ovarian cancer	1.06e-06	8.27e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC5A5—ovarian cancer	1.06e-06	8.22e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—YAP1—ovarian cancer	1.05e-06	8.18e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TYMS—ovarian cancer	1.05e-06	8.16e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN1B—ovarian cancer	1.05e-06	8.16e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.04e-06	8.1e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CD—ovarian cancer	1.04e-06	8.08e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CA—ovarian cancer	1.03e-06	8.01e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC2A1—ovarian cancer	1.02e-06	7.94e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ABCB1—ovarian cancer	1.01e-06	7.85e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TYMS—ovarian cancer	9.89e-07	7.71e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CTNNB1—ovarian cancer	9.89e-07	7.7e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP1B1—ovarian cancer	9.77e-07	7.61e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTEN—ovarian cancer	9.64e-07	7.51e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CD—ovarian cancer	9.43e-07	7.35e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CB—ovarian cancer	9.34e-07	7.28e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CD—ovarian cancer	9.33e-07	7.27e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.14e-07	7.12e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CB—ovarian cancer	9.03e-07	7.04e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPP2R1A—ovarian cancer	8.66e-07	6.75e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—STAT3—ovarian cancer	8.62e-07	6.72e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NRAS—ovarian cancer	8.6e-07	6.7e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—FASN—ovarian cancer	8.56e-07	6.67e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CAV1—ovarian cancer	8.44e-07	6.57e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC5A5—ovarian cancer	8.42e-07	6.56e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—AKT1—ovarian cancer	8.4e-07	6.54e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MAPK3—ovarian cancer	8.24e-07	6.42e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CB—ovarian cancer	8.22e-07	6.4e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC2A1—ovarian cancer	8.14e-07	6.34e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CB—ovarian cancer	8.13e-07	6.34e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—YAP1—ovarian cancer	8.11e-07	6.32e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTEN—ovarian cancer	8.07e-07	6.29e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MYC—ovarian cancer	8.01e-07	6.24e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CAV1—ovarian cancer	7.97e-07	6.21e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.97e-07	6.21e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TYMS—ovarian cancer	7.9e-07	6.16e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MAPK1—ovarian cancer	7.84e-07	6.11e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGFR—ovarian cancer	7.83e-07	6.1e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTEN—ovarian cancer	7.81e-07	6.08e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP1B1—ovarian cancer	7.8e-07	6.08e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CG—ovarian cancer	7.69e-07	5.99e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.62e-07	5.93e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CA—ovarian cancer	7.58e-07	5.91e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KRAS—ovarian cancer	7.4e-07	5.77e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CG—ovarian cancer	7.26e-07	5.66e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTEN—ovarian cancer	7.1e-07	5.53e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTEN—ovarian cancer	7.03e-07	5.48e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	6.92e-07	5.39e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.88e-07	5.36e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CA—ovarian cancer	6.8e-07	5.3e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CD—ovarian cancer	6.76e-07	5.26e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—FASN—ovarian cancer	6.61e-07	5.15e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC5A5—ovarian cancer	6.5e-07	5.06e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ABCB1—ovarian cancer	6.42e-07	5e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CD—ovarian cancer	6.38e-07	4.97e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CAV1—ovarian cancer	6.37e-07	4.96e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TYMS—ovarian cancer	6.31e-07	4.91e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HRAS—ovarian cancer	6.29e-07	4.9e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC2A1—ovarian cancer	6.28e-07	4.89e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKT1—ovarian cancer	6.19e-07	4.82e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IL6—ovarian cancer	6.02e-07	4.69e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP1B1—ovarian cancer	6.02e-07	4.69e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CB—ovarian cancer	5.89e-07	4.59e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CG—ovarian cancer	5.8e-07	4.52e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CA—ovarian cancer	5.69e-07	4.44e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CB—ovarian cancer	5.56e-07	4.33e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT1—ovarian cancer	5.55e-07	4.33e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CA—ovarian cancer	5.51e-07	4.29e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	5.34e-07	4.16e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CD—ovarian cancer	5.1e-07	3.97e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTEN—ovarian cancer	5.09e-07	3.96e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CAV1—ovarian cancer	5.08e-07	3.96e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CA—ovarian cancer	5.01e-07	3.9e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CA—ovarian cancer	4.96e-07	3.86e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.96e-07	3.86e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TYMS—ovarian cancer	4.87e-07	3.79e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.86e-07	3.78e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTEN—ovarian cancer	4.81e-07	3.75e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKT1—ovarian cancer	4.65e-07	3.62e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CG—ovarian cancer	4.63e-07	3.61e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKT1—ovarian cancer	4.5e-07	3.51e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CB—ovarian cancer	4.44e-07	3.46e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKT1—ovarian cancer	4.09e-07	3.19e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CD—ovarian cancer	4.07e-07	3.17e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKT1—ovarian cancer	4.05e-07	3.16e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CAV1—ovarian cancer	3.92e-07	3.06e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTEN—ovarian cancer	3.84e-07	2.99e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CA—ovarian cancer	3.59e-07	2.8e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.57e-07	2.78e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CB—ovarian cancer	3.55e-07	2.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CA—ovarian cancer	3.39e-07	2.64e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.14e-07	2.45e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTEN—ovarian cancer	3.07e-07	2.39e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKT1—ovarian cancer	2.93e-07	2.29e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKT1—ovarian cancer	2.77e-07	2.16e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.74e-07	2.13e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.71e-07	2.11e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTEN—ovarian cancer	2.37e-07	1.84e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKT1—ovarian cancer	2.21e-07	1.72e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CA—ovarian cancer	2.16e-07	1.68e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKT1—ovarian cancer	1.77e-07	1.38e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.67e-07	1.3e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKT1—ovarian cancer	1.36e-07	1.06e-05	CbGpPWpGaD
